Progyny, Inc. (PGNY) has 336 open-market insider trades by 18 insiders since 2019. Over the last six months insiders net sold $1.0M. The most active filer is Norman Payson, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. via James G. Coulter | 10% Owner | — | 15 | $355.3M | 2021-07-06 |
| David J. Schlanger | Chairman | — | 59 | $212.1M | 2026-01-02 |
| David Bonderman | — | — | 17 | $203.4M | 2023-08-07 |
| Peter Anevski | CEO | — | 56 | $139.5M | 2026-09-03 |
| James G. Coulter | 10% Owner | — | 26 | $104.9M | 2021-07-02 |
| Glaxosmithkline PLC | 10% Owner | — | 1 | $103.0M | 2020-05-20 |
| Norman Payson | Dir | — | 110 | $68.6M | 2026-05-21 |
| Jon Winkelried | 10% Owner | — | 1 | $29.1M | 2022-11-07 |
| Karin Ajmani | VP | — | 1 | $9.4M | 2020-02-19 |
| Mark S. Livingston | CFO | — | 5 | $7.0M | 2026-09-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Melissa B. Cummings | COO | Sell | $53K | 2026-10-14 |
| Allison Swartz | VP | Sell | $102K | 2026-09-23 |
| Kevin K. Gordon | Director | Sell | $312K | 2026-09-10 |
| Kevin K. Gordon | Director | Sell | $321K | 2026-09-10 |
| Melissa B. Cummings | COO | Sell | $71K | 2026-07-14 |
| Mark S. Livingston | CFO | Sell | $64K | 2026-06-04 |
Companies that share insiders with PGNY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Allison Swartz | VP | Sell | $45K | 2026-06-03 |
| Geoffrey Clapp | CPO | Sell | $39K | 2026-06-02 |
| Mark S. Livingston | CFO | Sell | $7K | 2026-06-02 |
| Cheryl Scott | Director | Sell | $196K | 2026-06-01 |
| Allison Swartz | VP | Sell | $61K | 2026-05-28 |
| Kevin K. Gordon | Director | Sell | $137K | 2026-05-27 |
| Mark S. Livingston | CFO | Sell | $211K | 2026-05-20 |
| Melissa B. Cummings | COO | Sell | $239K | 2026-05-19 |
| Allison Swartz | EVP & GC | Sell | $11K | 2026-03-04 |